Your browser doesn't support javascript.
loading
Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist.
Zebala, John A; Schuler, Aaron D; Kahn, Stuart J; Maeda, Dean Y.
Afiliação
  • Zebala JA; Department of Chemistry and Preclinical Development, Syntrix Pharmaceuticals, Auburn, WA, United States.
  • Schuler AD; Department of Chemistry and Preclinical Development, Syntrix Pharmaceuticals, Auburn, WA, United States.
  • Kahn SJ; Department of Chemistry and Preclinical Development, Syntrix Pharmaceuticals, Auburn, WA, United States.
  • Maeda DY; Department of Chemistry and Preclinical Development, Syntrix Pharmaceuticals, Auburn, WA, United States.
Front Pharmacol ; 10: 1680, 2019.
Article em En | MEDLINE | ID: mdl-32116679
ABSTRACT
Tramadol is widely used globally and is the second most prescribed opioid in the United States. It treats moderate to severe pain but lethal opioid-induced respiratory depression is uncommon even in large overdose. It is unknown why tramadol spares respiration. Here we show its active metabolite, desmetramadol, is as effective as morphine, oxycodone and fentanyl in eliciting G protein coupling at the human µ opioid receptor (MOR), but surprisingly, supratherapeutic concentrations spare human MOR-mediated ßarrestin2 recruitment thought to mediate lethal opioid-induced respiratory depression.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article